Product search
Filter
Search results
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
LIAPHEN Antithrombin
Assay of AT in human citrated plasma.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin 2.5 (Anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
ZYMUTEST Annexin V Antigen
Assay proposed for the measurement of annexin V in research applications.
BIOPHEN α2-Antiplasmin (Plasmin Inhibitor) LRT
Assay proposed for the measurement of plasmin inhibitor (α2-antiplasmin) activity in research applications.
α1-Antitrypsin EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
CoaChrom® α1-Antitrypsin
Assay proposed for the measurement of α1-antitrypsin (α1-AT, α1-proteinase inhibitor) in human plasma. For research use only.
CEPHEN APTT 5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
CEPHEN APTT 2.5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.